1984
DOI: 10.1016/s0040-4039(01)81506-9
|View full text |Cite
|
Sign up to set email alerts
|

Mild Arbuzov reactions of phosphonous acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0
2

Year Published

1985
1985
2016
2016

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(24 citation statements)
references
References 3 publications
0
22
0
2
Order By: Relevance
“…Finally, the reaction of unactivated (bromomethyl)phthalimide was examined using the more common silylation (HMDS/TMSCl) 17 from the diastereoisomeric mixture (mother liquor) of 2. As shown in eqn (2), the overall yield was reasonable and the stereoselectivity excellent.…”
Section: Menthyl(hydroxymethyl)phosphinatesmentioning
confidence: 99%
“…Finally, the reaction of unactivated (bromomethyl)phthalimide was examined using the more common silylation (HMDS/TMSCl) 17 from the diastereoisomeric mixture (mother liquor) of 2. As shown in eqn (2), the overall yield was reasonable and the stereoselectivity excellent.…”
Section: Menthyl(hydroxymethyl)phosphinatesmentioning
confidence: 99%
“…The answer to the question of why this process is limited to Ph 2 PÀOR compounds is not clear. Tentatively, this could be accounted for in terms of a pronounced tendency to form the structure Ph 2 P À P(O)Ph 2 (21).…”
Section: Synthesis Of [Ar 2 Pr 2 ]mentioning
confidence: 99%
“…A similar sequence of "group introduction" has been explored subsequently to generate a series of phosphinothricin analogues (37), derivatised at the phosphinylmethyl position in order to optimise E.I. interactions with glutamine synthetase [26], employing a "mild Arbuzov" approach to C-P bond formation [27,28] (Scheme 5b). Treatment of the methyl-derivatised phosphinic acids 38 with hexamethyldisilazane yielded the requisite bis(trimethylsilyl) phosphonites 39 [28] in order to elicit low temperature, Arbuzov-type substitutions with methyl (2S)-N-benzyloxycarbonyl-2-amino-4-iodobutyrate (40) [26].…”
Section: Scheme 3 [17]mentioning
confidence: 99%